Skip to main content

Research Repository

Advanced Search

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro

Miller, Suzanne; Henry, Amanda P.; Hodge, Emily; Kheirallah, Alexander K.; Billington, Charlotte K.; Rimington, Tracy L.; Bhaker, Sangita K.; Obeidat, Ma�en; Mel�n, Erik; Merid, Simon K.; Swan, Caroline; Gowland, Catherine; Nelson, Carl P.; Stewart, Ceri E.; Bolton, Charlotte E.; Kilty, Iain; Malarstig, Anders; Parker, Stuart G.; Moffatt, Miriam F.; Wardlaw, Andrew J.; Hall, Ian P.; Sayers, Ian

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro Thumbnail


Senior Clinical Studies and Project Manager

Amanda P. Henry

Emily Hodge

Alexander K. Kheirallah

Charlotte K. Billington

Tracy L. Rimington

Sangita K. Bhaker

Ma�en Obeidat

Erik Mel�n

Simon K. Merid

Caroline Swan

Catherine Gowland

Carl P. Nelson

Ceri E. Stewart

Iain Kilty

Anders Malarstig

Stuart G. Parker

Miriam F. Moffatt

Andrew J. Wardlaw

Professor of Molecular Medicine



Genome-Wide Association Studies have identified associations between lung function measures and Chronic Obstructive Pulmonary Disease (COPD) and chromosome region 6p21 containing the gene for the Advanced Glycation End Product Receptor (AGER, encoding RAGE). We aimed to (i) characterise RAGE expression in the lung, (ii) identify AGER transcripts, (iii) ascertain if SNP rs2070600 (Gly82Ser C/T) is associated with lung function and serum sRAGE levels and (iv) identify whether the Gly82Ser variant is functionally important in altering sRAGE levels in an airway epithelial cell model.


Immunohistochemistry was used to identify RAGE protein expression in 26 human tissues and qPCR was used to quantify AGER mRNA in lung cells. Gene expression array data was used to identify AGER expression during lung development in 38 fetal lung samples. RNA-Seq was used to identify AGER transcripts in lung cells. sRAGE levels were assessed in cells and patient serum by ELISA. BEAS2B-R1 cells were transfected to overexpress RAGE protein with either the Gly82 or Ser82 variant and sRAGE levels identified.


Immunohistochemical assessment of 6 adult lung samples identified high RAGE expression in the alveoli of healthy adults and individuals with COPD. AGER/RAGE expression increased across developmental stages in human fetal lung at both the mRNA (38 samples) and protein levels (20 samples). Extensive AGER splicing was identified. The rs2070600T (Ser82) allele is associated with higher FEV1, FEV1/FVC and lower serum sRAGE levels in UK smokers. Using an airway epithelium model overexpressing the Gly82 or Ser82 variants we found that HMGB1 activation of the RAGE-Ser82 receptor results in lower sRAGE production.


This study provides new information regarding the expression profile and potential role of RAGE in the human lung and shows a functional role of the Gly82Ser variant. These findings advance our understanding of the potential mechanisms underlying COPD particularly for carriers of this AGER polymorphism.

Journal Article Type Article
Acceptance Date Sep 19, 2016
Online Publication Date Oct 18, 2016
Publication Date Oct 18, 2016
Deposit Date Nov 2, 2016
Publicly Available Date Nov 2, 2016
Journal PLOS ONE
Electronic ISSN 1932-6203
Publisher Public Library of Science
Peer Reviewed Peer Reviewed
Volume 11
Issue 10
Article Number e0164041
Public URL
Publisher URL


You might also like

Downloadable Citations